Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Third Avenue Small Cap Value Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trademark low-turnover, balance-sheet-focused approach."
In Q3 2025, the Third Avenue Small-Cap Value Fund returned 7.18%, underperforming its primary benchmark, the MSCI USA Small Cap Value Index, which returned 8.97%. Positive quarterly contributors included Supernus Pharmaceuticals, Investors Title, and UMB Financial, while detractors included Atlanta Braves Holdings, UniFirst, and FRP Holdings. The managers highlighted their long-term value strategy focused on well-capitalized companies in transition ('small-cap chrysalises'), which permits a low annual turnover rate of ~20% (average 5-year holding period). Notable portfolio changes included new positions in Boise Cascade and Rogers Corporation, additions to UniFirst, and a complete exit from Hamilton Beach Brands, leaving cash at 4.5%.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
Growth Outlook
Market outlook remains above average conviction: The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
Risk Appetite
Risk appetite posture is above average conviction: The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
Forward Guidance
Forward guidance signal: The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
Language Signal
Tone analysis indicates above average conviction language: The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Fund returned 7.18% in Q3 2025, underperforming benchmarks, but deployed capital into new transitional value plays in Boise Cascade and Rogers Corporation, leveraging its trade...
